Top news of the week: 08.04.2021.
Startups
Biotech Investing Impact in Price-Controlled Future
Wednesday, April 7 at 7:00pm EDT with Chris Garabedian, Peter Kolchinsky, Luke Timmerman, Stefan Prisacaru, Jeb Keiper. Can biotech startups attract investment in a price-controlled future? ...
The Glory of John Martin: an Understated Leader Who Built a Biotech Powerhouse
John C. Martin was an unassuming man with an ordinary name. But his leadership qualities and accomplishments as a biopharma CEO were extraordinary. Martin, the CEO of Foster City, Calif. ...
Jackpot: Ten New Billionaires From IPOs In 2021
Despite the SPAC boom, far more entrepreneurs became billionaires this year through a good old-fashioned traditional IPO.
Sinovac aims to pump out 2B COVID-19 vaccine doses a year, courtesy of third production line
Just a few months ago, China's Sinovac said it had capacity for just 300 million COVID-19 vaccine doses per year. In February, when the shot scored approval in China, Sinovac said it had ...
Member Spotlight: Q&A with PRA Health Sciences
In April, we spoke with Brandon Early, Vice President for Project Delivery, PRA Health Sciences.
No Sputnik V approval yet, SEC asks Dr Reddy's for more data on vax
The Subject Expert Committee (SEC) of the Indian drug regulator, tasked with vetting Covid-19 vaccine proposals, sought additional data on Russian Covid-19 vaccine 'Sputnik V'
Iveric Bio's executive chair, founder Guyer steps down, rejoins SV Health Investors
A founding member of eye disease and gene therapy biotech Iveric Bio, David Guyer, M.D., is stepping down from his executive chair role and leaving the board of the company he helped build.
Meet The 40 New Billionaires Who Got Rich Fighting Covid-19
Some made their fortunes developing new vaccines and promising antibody treatments, while others sell much-needed diagnostic tests and personal protective equipment.